Tilray Inc (NASDAQ:TLRY - Get Free Report) fell 5.3% on Thursday . The stock traded as low as $0.60 and last traded at $0.61. 12,245,278 shares changed hands during trading, a decline of 73% from the average session volume of 45,057,148 shares. The stock had previously closed at $0.64.
Analysts Set New Price Targets
Separately, Canaccord Genuity Group boosted their price objective on Tilray from $2.00 to $3.00 and gave the stock a "buy" rating in a research report on Monday, January 13th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $2.70.
Check Out Our Latest Report on Tilray
Tilray Stock Up 3.5 %
The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58. The stock has a market capitalization of $571.88 million, a P/E ratio of -2.03 and a beta of 2.13. The firm has a 50 day moving average of $0.98 and a 200-day moving average of $1.34.
Tilray (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings results on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.07). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm had revenue of $210.90 million for the quarter, compared to the consensus estimate of $216.34 million. The business's revenue for the quarter was up 8.7% compared to the same quarter last year. On average, equities research analysts expect that Tilray Inc will post -0.2 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Tilray
Large investors have recently modified their holdings of the stock. Lido Advisors LLC bought a new stake in shares of Tilray in the 4th quarter valued at approximately $28,000. Dudley Capital Management LLC bought a new stake in shares of Tilray in the 4th quarter valued at approximately $29,000. Verdence Capital Advisors LLC bought a new stake in shares of Tilray in the 4th quarter valued at approximately $29,000. Ameritas Advisory Services LLC bought a new stake in shares of Tilray in the 4th quarter valued at approximately $32,000. Finally, Newman Dignan & Sheerar Inc. grew its position in Tilray by 61.9% during the 4th quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock worth $35,000 after acquiring an additional 10,000 shares during the last quarter. 9.35% of the stock is currently owned by institutional investors.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Further Reading
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
